| Literature DB >> 34745916 |
Mahmoud Hosseini1, Mohammad Hossein Boskabady2, Mohammad Reza Khazdair3.
Abstract
OBJECTIVE: Coriander (Coriandrum sativum L.) is an annual herb belonging to the Apiaceae (Umbellifera) family that is used as food additives traditionally. This plant is called "Geshniz" in Persian and is native to Mediterranean regions but it is currently cultivated in several countries. All parts of coriander are edible and have been traditionally used to treat different disorders, including digestive problems, flatulence, diarrhea, colic and other gastrointestinal diseases.Entities:
Keywords: Coriandrum sativum L.; Linalool; Memory impairment; Neuro-pharmacological effects
Year: 2021 PMID: 34745916 PMCID: PMC8554282 DOI: 10.22038/AJP.2021.55681.2786
Source DB: PubMed Journal: Avicenna J Phytomed ISSN: 2228-7930
Figure 1Leaf (left), flower (middle) and seeds (right) of coriander (Asgarpanah and Kazemivash, 2012)
Sedative, anti-anxiety and anti-depressive effects of C. sativum and linalool
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Aqueous fresh leaves | Traditional medicine | - | Anxiety relieving and insomnia treating. | (Mir, 1992 | |
| Aqueous fresh leaves | Traditional medicine | - | Anxiety relieving and insomnia treating. | (Duke, 2002 | |
| Aqueous seed extract | Elevated plus maze in mice | 10, 25, 50, 100 mg/kg, i.p. | Increasing the time spent on elevated plus maze open arms motor activity and neuromuscular function impairments. | (Emamghoreishi et al., 2005 | |
| Aqueous seed extract | Pentobarbital-induced hypnosis in mice | 100, 200, 400 and 600 mg/kg, i.p. | 200, 400 and 600 mg/kg of the extract prolonged duration of sleeping time. | (Emamghoreishi and Heidari-Hamedani, 2015 | |
| Hydroalcoholic seed extract | Pentobarbital-induced hypnosis in mice | 100, 200, 400 and 600 mg/kg, i.p. | 400 and 600 mg/kg of the extract increased duration of sleeping time | (Emamghoreishi and Heidari-Hamedani, 2015 | |
| Essential oil of seed | Pentobarbital-induced hypnosis in mice | 100, 200, 400 and 600 mg/kg, i.p. | Only 600 mg/kg of essential oil of seeds increased duration of sleeping time | (Emamghoreishi and Heidari-Hamedani, 2015 | |
| Aqueous leaves extract | Elevated plus maze in mice | 50, 100 and 200 mg/kg, i.p. | 200 mg/kg of the extract increased the time spent on and the number of entries into the open arms | (Pathan et al., 2011 | |
| Hydroalcoholic seed extract | Induced anxiety in mice | 50, 100 and 200 mg/kg, i.p. | Similar to 0.5 mg/kg diazepam, 100 and 200 mg/kg of the extract attenuated anxiety like behaviors | (Mahendra and Bisht, 2011 | |
| An extract obtained from fresh and dried plant | Induced depression in mice | 10 ml/kg, i.p. | The extract from fresh plant had an anti-depression effect | (Kishore and Siddiqui, 2003 | |
| Aqueous extracts and extract obtained by diethyl ether | Induced depression in mice | 200 and 400 mg/kg, p.o. | Showed anti-depressant like activity comparable to the effects of fluoxetine and imipramine | (Kharade et al., 2011 | |
| Diethyl ether extract from the seeds | Induced depression in mice | 6 and 8 ml/kg, p.o. | Showed better bioactivity than aqueous seeds extract | (Kharade et al. 2011 | |
| Coriander oil and linalool | Induced anxiety in chick | 0.86, 8.6 and 86 μg/chick, i.c.v. | Distress calls, escapes, defecation and crossing number on open field test were decreased, while sleeping posture was increased | (Gastón et al., 2016 | |
| Inhalation coriander oil | Induced Alzheimer's disease in rat | 1% and 3% | Increased time spent in the open arms, open-arm entries and the number of crossing in rat model of Alzheimer's disease. | (Cioanca et al., 2014 | |
|
| Induced seizure in rat | 50, 100 and 200 mg/kg | Reduced duration, frequency and amplitude of the burst discharges while prolonged the latency of the seizure attacks. The extract also prevented from production of dark neurons and apoptotic cells in different areas of the hippocampus | (Pourzaki et al., 2017 | |
| Inhaled linalool | Induced anxiety in mice | 1% and 3% | Linalool 3% decreased exploring and motor activities. Linalool (1% and 3%) increased sleeping time and reduced body temperature. | (de Moura Linck et al., 2009 | |
| Inhaled linalool | Induced anxiety in mice | 1% and 3% | Linalool (3%) increased exploring behavior comparable to the effects of diazepam (1.0 mg/kg, i.p.) | (Linck et al., 2010 | |
| Inhaled linalool oxide | Induced anxiety in mice | 0.65%, 2.5% and 5.0% (w/w) | Increased open entries and open arm duration and also increased the time spent on light compartment. | (Souto-Maior et al., 2011 | |
| linalool | Induced depression in rat | 30 mg/kg, p.o. | Showed antidepressant activity by increased latency time and self-cleaning time, while decreased immobility time. | (dos Santos et al., 2018 | |
| Linalool | Induced anxiety in mice | 100 mg/kg, i.p. | Improved the cognitive performance and decreased the prolonged time in dark chamber of model mice. Linalool also reduced the pathological lesions induced by AB to normal range. It also increased SOD and GPX activities in the hippocampus and cortex compared to the induced animals, while decreased the MDA level in the cortex close to the sham group | (Xu et al., 2017 | |
| linalool | Induced Alzheimer's disease in mice | 25 mg/kg, p.o. | Improved learning and spatial memory and significantly reduced extracellular β-amyloidosis, astrogliosis and microgliosis as well as reduced the levels of the pro-inflammatory markers including; p38 MAPK, COX2 and IL-1β in hippocampi and amygdalae. | (Sabogal-Guáqueta et al., 2016 | |
Anticonvulsant and anti-seizure activity of C. sativum and linalool
|
|
|
|
|
|
|---|---|---|---|---|
| The seeds aqueous extract | Induced seizure in mice | 0.5 g/kg, i.p. | Tonic seizures duration was decreased, clonic convulsion onsets were postponed. | (Hosseinzadeh and Madanifard, 2000 |
| The seeds ethanolic extract | 3.5 and 5 g/kg, i.p. | Tonic seizures duration was decreased, clonic convulsion onsets were postponed. | (Hosseinzadeh and Madanifard, 2000 | |
| Aqueous and ethanolic extracts and essential oil | 200, 400, 600 and 800 mg/kg, i.p. | Myoclonic and clonic seizures onsets were postponed. | (Emamghoreishi and Heidari-Hamedani, 2010 | |
| The seeds hydroalcoholic extract and essential oil | 5 mg/kg, i.p. | Myoclonic and clonic seizures onsets were postponed. | (Emam and Heydari, 2008 | |
| The leaves hydroalcoholic extract | PTZ- induced seizure in rat | 100, 500 and 1000 mg/kg, i.p. | MCS and GTCS latencies were increased | (Karami et al., 2015 |
| Aerial parts fractions | 25 and 100 mg/kg, i.p. | GTCS latency was significantly improved Hippocampal MDA concentrations were decreased cortical and hippocampal tissues thiol contents were improved. | (Anaeigoudari et al., 2016 | |
| Linalool |
| 0.3 mM or 1.0 mM | Modulated glutamate activation expression in the rat cortex membrane cells. | (da-Silva et al., 1990 |
| Linalool | Quinolinic acid induced seizure in rat | 350 mg/kg, i.p. | Linalool delayed of NMDA (270mg/kg, i.p.) induced seizures onsets which was comparable to the effects of diazepam. | (da-Silva et al. 1990 |
| Linalool | Quinolinic acid induced seizure in mic | 1.0 or 3.0 mM | Reduced potassium-stimulated glutamate release as well as glutamate uptake (90%) | (Brum et al., 2001 |
Memory improving and anti-Alzheimer’s disease properties of C. sativum and linalool
|
|
|
|
|
|
|---|---|---|---|---|
| Coriander volatile oil | Induced Alzheimer's disease in rats | 1 and 3% | Improved and reversed the deleterious effects of amyloid ß. | (Cioanca et al., 2013 |
| Coriander volatile oil | 1 and 3% | Enhanced the swimming time and attenuated the immobility times | (Cioanca et al., 2014 | |
| Aqueous seed extract | 0.5 mg/kg, p.o. | Restored deleterious effects on pyramidal cells. | (Enas, 2010 | |
| Aqueous fruit extract | 100, 200 and 300 mg/kg | Decreased VMA urinary levels in stress-induced animal model while, increased excretion of ascorbic acid. | (Koppula and Choi, 2012 | |
| Leaves mixed in diet | 5, 10 and 15% (w/w) | Improved memory scores in aged and young rats. | (Mani and Parle, 2009 | |
| Ethanolic leaves extract | 200 mg/kg; i.p. | Increased the latencies of seizure onsets which was accompanied with a decreased latency to find the platform. | (Elahdadi-Salmani et al., 2015 | |
| Ethanolic seeds extract | 100 and 200 mg/kg, p.o. | Decreased VCM, TP and OB behaviors induced by tacrine, and improved locomotor activity and cognitive functions. | (Mohan et al., 2015 | |
| Linalool | Induced Alzheimer's disease in mice | 25 mg/kg, p.o. | Showed a higher retention performance. | (Sabogal-Guáqueta et al., 2016 |
| Inhaled linalool | 1% | The social interactions were increased. | (Linck et al., 2010 |
The effects of C. sativum and its components on neurotoxicity
|
|
|
|
|
|
|---|---|---|---|---|
| The leaves methanolic extract | Ischemic rat model | 200 mg/kg, p.o., | Increased total proteins, superoxide dismutase, catalase and glutathione while, attenuated cerebral infarcted volume, prevented form increasing of lipid peroxidation and calcium levels in the ischemic rat brain. | (Vekaria et al., 2012 |
| WF, EAF and NBF of |
| 0.1, 0.2, 0.4, and 0.8 mg/ml | WF at 0.4, 0.8 and 1.6 mg/ml significantly reduced glucose/serum deprivation-induced cytotoxicity. | (Ghorbani et al., 2011 |
| Linalool |
| 16 µg/ml | Significantly improved cell viability | (Alinejad et al., 2013 |
| Linalool | Acrylamide (ACR) induced neural damage in rat | 12.5, 25, 50 and 100 mg/kg i.p. | Significantly reduced severe gait abnormalities induced by ACR | (Mehri et al., 2015 |
| Linalool |
| 0.01, 0.1, 1 and 10 µm | Significantly attenuated intracellular oxidative damages in OGD/R model. | (Park et al., 2016a |
| Linalool |
| 1 µm, 2.5 µm, and 5 µm | Increased neuronal cell viability (about 60% cell viability) and significantly prevented from NO over- production. Linalool also improved antioxidant status. | (Kim et al., 2015 |
| Linalool |
| 10 μM | Showed therapeutically effects in treating ischemia-induced cerebral neuronal injury, by inhibition of oxidative stress and inflammatory responses. | (Park et al., 2016b |
| Linalool | ACR-induced neural damage in rat | 12.5 mg/kg, i.p. | Showed neuroprotective effects by reducing the progressive gait abnormalities promoted by acrylamide, oxidative stress, lipid peroxidation, and increasing the levels of glutathione (GSH) | (Mehri et al., 2015 |
| Beta-myrcene (MYR) | Induced ischemia in mice | 200 mg/kg; i.p. | Decreased in the antioxidant factors including, GSH, catalase, glutathione peroxidase (GPX) and SOD. | (Ciftci et al., 2014 |